Innerer Wert von S&P & Nasdaq Kontaktieren

Heska Corporation HSKA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$159.50
+32.9%

Heska Corporation (HSKA) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Loveland, CO, United States. Der aktuelle CEO ist Kevin S. Wilson.

HSKA hat IPO-Datum 1997-07-01, 808 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke, eine Marktkapitalisierung von $1.31B.

Über Heska Corporation

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

📍 3760 Rocky Mountain Avenue, Loveland, CO 80538 📞 970 493 7272
Unternehmensdetails
SektorGesundheitswesen
BrancheMedical - Devices
LandUnited States
BörseNASDAQ Capital Marke
WährungUSD
IPO-Datum1997-07-01
CEOKevin S. Wilson
Mitarbeiter808
Handelsinformationen
Aktueller Kurs$119.99
Marktkapitalisierung$1.31B
52-Wochen-Spanne57.83-120.03
Beta1.60
ETFNein
ADRNein
CUSIP42805E306
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden